Andrew Bourne Joins Bergeson & Campbell, P.C.’s Affiliate, The Acta Group EU, Ltd, and Brings Valuable Experience in International Chemical Regulatory Matters
Bergeson & Campbell, P.C. (B&C), B&C Consortia Management, L.L.C. (BCCM), The Acta Group, L.L.C. (Acta), and The Acta Group EU, Ltd (Acta EU) are pleased to announce the addition of Andrew Bourne to its European Union consulting practice. Mr. Bourne’s experience in international chemical regulatory programs will supplement the skill sets of other Acta EU professionals and provide even greater service to our growing client base.
Mr. Bourne previously worked for Exponent International Ltd. (Exponent) as a Regulatory Affairs Specialist where he was a liaison for Substance Information Exchange Forum (SIEF) members, steering groups, and downstream users for the compilation of substance identification and available substance data and risk management information for the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) phase-in 2010 deadlines. In addition, he produced several Chemical Safety Reports (CSR) for Annex IX and X registrations and assisted in biocides and plant protection registrations. Prior to his work at Exponent, Mr. Bourne was a Regulatory Affairs Officer at Harlan Laboratories Ltd., where he managed non-phase-in and worldwide registrations and notifications of chemical substances and produced training documents for REACH. Mr. Bourne has a degree in environmental science and environmental management.
About Bergeson & Campbell, P.C. — Located in Washington, D.C., B&C is a law firm focusing on conventional and nanoscale industrial, agricultural, and specialty chemical product regulation and approval matters, medical device and product approval, registration and data compensation arbitrations, chemical product litigation, and associated business counseling and litigation issues. Clients are involved in many businesses, including conventional and nanoscale basic, specialty, and agricultural and antimicrobial chemicals; biotechnology, nanotechnology, and emerging transformative technologies; pharmaceuticals, medical devices, and diagnostic products; fibers; paints and coatings; printing and publishing; and plastic products. Additional information is available at www.lawbc.com.
About B&C Consortia Management, L.L.C. — BCCM, an affiliate of B&C, has strong institutional experience in consortia management. BCCM provides cost effective administrative and management services to consortia to ensure their interests are protected and their voices heard on issues of concern. BCCM works with industry groups to develop or expand advocacy and/or product stewardship programs, to develop and conduct communications outreach to local, state, federal, or international government entities, to formulate and initiate research programs — whether voluntary or in response to regulatory requirements, and many other activities. Additional information is available at www.bc-cm.com.
About The Acta Group, L.L.C. and The Acta Group EU, Ltd — The Acta Group, L.L.C. (Acta) and The Acta Group EU, Ltd (Acta EU) are consulting affiliates of B&C, established to control the spiraling costs and inefficiencies encountered by clients seeking approvals to market agricultural and industrial chemicals, products of biotechnology and nanotechnology, and Food and Drug Administration-regulated products. Acta and Acta EU manage products from concept to approval, utilizing the skills and experience of professionals who have worked in the specific product areas in government and industry. Additional information is available at www.actagroup.com.